Download PDF
Nervenheilkunde 2009; 28(06): 356-360
DOI: 10.1055/s-0038-1628651
Thema zum Schwerpunkt
Schattauer GmbH

Was ist chronische Migräne?

What is chronic migraine?
A. Straube
1   Neurologie der Universität München
,
A. May
2   Institut für systemische Neurowissenschaften der Universitätsklinik Hamburg (UKE)
,
W. Paulus
3   Abteilung für Klinische Neurophysiologie, Universitätsmedizin Göttingen
,
T.-M. Wallasch
4   Klinik für Interdisziplinäre Schmerztherapie am Sankt Gertrauden Krankenhaus Berlin, Lehrkrankenhaus der Charité
› Author Affiliations
Further Information

Publication History

Received Eingegangen am: 29 August 2008

Accepted angenommen am: 10 September 2008

Publication Date:
24 January 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die IHS-Kriterien definieren vier primäre Kopfschmerzerkrankungen, die zu täglichen Dauerkopfschmerzen führen können: chronische Migräne, Kopfschmerz vom Spannungstyp, Hemicrania continua und neu aufgetretener Kopfschmerz. Abzugrenzen ist der als ein sekundärer Kopfschmerz klassifizierte Kopfschmerz durch Medikamentenübergebrauch (früher: Analgetikakopfschmerz). Zu der häufigsten primären Form gehört die chronische Migräne, bei der in etwa 80% ein Medikamentenübergebrauch beobachtet werden kann. In diesem Rahmen wird diskutiert, an wie vielen Tagen des Monats der Kopfschmerz Migränecharakter haben muss und an wie vielen Tagen der Kopfschmerz eher einem Spannungskopfschmerz ähneln darf, um trotzdem noch für die Definition “chronische Migräne” zu qualifizieren. Inwieweit ein Medikamentenübergebrauch alleinig für die Chronifizierung einer primär episodischen Migräne verantwortlich ist und ob es sich bei der chronischen Migräne primär um eine Untergruppe der Migräneerkrankungen handelt, ist Gegenstand der aktuellen Forschung.

Summary

The IHS-criteria define four different primary headache syndromes with chronic daily headaches of more than four hours: chronic migraine, chronic tension type headache, hemicrania continua, new daily persisting headache. Medication overuse headache, a form of secondary headache, is a challenge in daily practice. There is still some debate about the definition of chronic migraine which is reflected in the recent definition of the so called appendix criteria by the IHS. It is currently discussed whether chronic migraine is mostly a complication of a current medication overuse on the background of a primary episodic migraine or indeed a biologically determined variant of migraine.

Schlüsselwörter

Chronischer täglicher Kopfschmerz - chronische Migräne - chronischer Kopfschmerz vom Spannungstyp - Hemicrania continua - neu aufgetretener Kopfschmerz - Kopfschmerz bei Medikamentenübergebrauch

Keywords

Chronic daily headache - chronic migraine - episodic and chronic tension type headache - hemicrania continua - new daily persisting headache - medication overuse headache
 

  • Literatur

  • 1 Aurora SK. et al. Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies. Headache 2007; 47 (07) 996-1003 discussion 1004-7.
    CrossrefPubMedGoogle Scholar
  • 2 Bahra A. et al. Does chronic daily headache arise de novo in association with regular use of analgesics?. Headache 2003; 43 (03) 179-90.
    CrossrefPubMedGoogle Scholar
  • 3 Bigal ME. et al. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Cephalalgia 2004; 24 (06) 483-90.
    CrossrefPubMedGoogle Scholar
  • 4 Bigal ME. et al. The classification of chronic daily headache in adolescents--a comparison between the second edition of the international classification of headache disorders and alternative diagnostic criteria. Headache 2005; 45 (05) 582-9.
    CrossrefPubMedGoogle Scholar
  • 5 Bigal ME. et al. Chronic migraine is an earlier stage of transformed migraine in adults. Neurology 2005; 65 (10) 1556-61.
    CrossrefPubMedGoogle Scholar
  • 6 Bigal ME, Liberman JN, Lipton RB. Age-dependent prevalence and clinical features of migraine. Neurology 2006; 67 (02) 246-51.
    CrossrefPubMedGoogle Scholar
  • 7 Bigal ME. et al. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology 2007; 68 (21) 1851-61.
    CrossrefPubMedGoogle Scholar
  • 8 Bigal ME, Lipton RB. Concepts and mechanisms of migraine chronification. Headache 2008; 48 (01) 7-15.
    PubMedGoogle Scholar
  • 9 Bøe MG, Mygland A, Salvesen R. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology 2007; 69 (01) 26-31.
    CrossrefPubMedGoogle Scholar
  • 10 Castillo J. et al. Epidemiology of chronic daily headache in the general population. Headache 1999; 39 (03) 190-6.
    CrossrefPubMedGoogle Scholar
  • 11 de Tommaso M. et al. Changes in cortical processing of pain in chronic migraine. Headache 2005; 45 (09) 1208-18.
    CrossrefPubMedGoogle Scholar
  • 12 de Tommaso M. et al. Abnormal brain processing of cutaneous pain in patients with chronic migraine. Pain 2003; 101 1-2 25-32.
    CrossrefPubMedGoogle Scholar
  • 13 Diener HC. et al. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 2007; 27 (07) 814-23.
    CrossrefPubMedGoogle Scholar
  • 14 Dodick DW. et al. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebocontrolled study. Headache 2005; 45 (04) 315-24.
    CrossrefPubMedGoogle Scholar
  • 15 Ferrari A. et al. Similarities and differences between chronic migraine and episodic migraine. Headache 2007; 47 (01) 65-72.
    CrossrefPubMedGoogle Scholar
  • 16 Grazzi L. et al. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up. Headache 2004; 44 (07) 678-83.
    CrossrefPubMedGoogle Scholar
  • 17 Headache Classification Committee of the IHS. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the IHS. Cephalalgia. 1988; 08 (Suppl. 07) 1-96.
    Google Scholar
  • 18 Headache Classification Subcommittee of the International Headache Society. The International Classificatiopn of Headache Disorders, 2nd Edition. Cephalalgia 2004; 24: 1-160.
    Google Scholar
  • 19 Headache Classification Committe. et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26 (06) 742-6.
    CrossrefPubMedGoogle Scholar
  • 20 Katsarava Z. et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004; 62 (05) 788-90.
    CrossrefPubMedGoogle Scholar
  • 21 Lantéri-Minet M. et al. The GRIM2005 study of migraine consultation in France I. Determinants of consultation for migraine headache in France. Cephalalgia 2007; 27 (12) 1386-97.
    CrossrefPubMedGoogle Scholar
  • 22 Limmroth V. et al. .Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002; 59 (07) 1011-4.
    CrossrefPubMedGoogle Scholar
  • 23 Luconi R. et al. Prognostic significance of personality profiles in patients with chronic migraine. Headache 2007; 47 (08) 1118-24.
    CrossrefPubMedGoogle Scholar
  • 24 Manzoni GC. et al. Classification of chronic daily headache by IHS criteria: limits and new proposals. Cephalalgia 1995; 15 (01) 37-43.
    PubMedGoogle Scholar
  • 25 Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache 1987; 27 (02) 102-6.
    CrossrefPubMedGoogle Scholar
  • 26 Meng ID, Cao L. From migraine to chronic daily headache: the biological basis of headache transformation. Headache 2007; 47 (08) 1251-8.
    CrossrefPubMedGoogle Scholar
  • 27 Nappi G. et al. Chronic Daily Headache. How Should it Be Included in the IHS Classification? Headache 1999; 39 (03) 197-203.
    PubMedGoogle Scholar
  • 28 Sarchielli P. et al. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid. Cephalalgia 2008; 28: 157-63.
    PubMedGoogle Scholar
  • 29 Scher A. et al. Prevalence of frequent headache in a population sample. Headache 1998; 38 (07) 497-506.
    CrossrefPubMedGoogle Scholar
  • 30 Scher AI. et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003; 106 1-2 81-9.
    CrossrefPubMedGoogle Scholar
  • 31 Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology 1994; 44 (10 Suppl 7): S6-16.
    CrossrefPubMedGoogle Scholar
  • 32 Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996; 47 (04) 871-5.
    CrossrefPubMedGoogle Scholar
  • 33 Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol 2000; 13 (03) 277-83.
    CrossrefPubMedGoogle Scholar
  • 34 Silberstein SD. et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache 2007; 47 (02) 170-80.
    CrossrefPubMedGoogle Scholar
  • 35 Straube A. et al. Therapie primärer chronischer Kopfschmerzen: Chronische Migräne, chronische Kopfschmerzen vom Spannungstyp und andere chronische tägliche Kopfschmerzen. Nervenheilkunde 2007; 03: 186-199.
    Article in Thieme ConnectGoogle Scholar
  • 36 Vieira DS. et al. Idiopathic intracranial hypertension with and without papilloedema in a consecutive series of patients with chronic migraine. Cephalalgia 2008; 28 (06) 609-13.
    CrossrefPubMedGoogle Scholar
  • 37 Welch KM. et al. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?. Headache 2001; 41 (07) 629-37.
    CrossrefPubMedGoogle Scholar
  • 38 Zwart J. et al. Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 2004; 61 (02) 160-4.
    Google Scholar